DIMENSIONAL FUND ADVISORS LP
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 354204
AUSTIN, TX
Position in VRDN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$29,603,639
+$19,241,477 QoQ
Shares Held
1,611,521
+204.2% QoQ
Ownership
1.42%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 215 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 90%
Shared 6%
None 3%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. VRDN ranks #50 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in VRDN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,603,639 | 1,611,521 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $10,362,162 | 529,763 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $17,290,083 | 555,594 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $13,784,805 | 638,777 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,790,056 | 485,698 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $1,072,062 | 55,924 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,441,070 | 327,080 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,399,615 | 107,580 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $176,325 | 10,070 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $219,324 | 10,070 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $154,473 | 10,070 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $239,565 | 10,070 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $277,957 | 10,926 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $332,935 | 11,398 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $233,772 | 11,398 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $131,874 | 11,398 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||